Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
Fedorova OV, Emelianov IV, Bagrov KA, Grigorova YN, Wei W, Juhasz O, Frolova EV, Marshall CA, Lakatta EG, Konradi AO, Bagrov AY.
Fedorova OV, et al. Among authors: marshall ca.
J Hypertens. 2015 Aug;33(8):1602-10. doi: 10.1097/HJH.0000000000000591.
J Hypertens. 2015.
PMID: 26136067
Free PMC article.